TY - JOUR
T1 - Auditory system involvement in late onset Pompe disease
T2 - A study of 20 Italian patients
AU - Musumeci, Olimpia
AU - Catalano, Natalia
AU - Barca, Emanuele
AU - Ravaglia, Sabrina
AU - Fiumara, Agata
AU - Gangemi, Giovanna
AU - Rodolico, Carmelo
AU - Sorge, Giovanni
AU - Vita, Giuseppe
AU - Galletti, Francesco
AU - Toscano, Antonio
PY - 2012/11
Y1 - 2012/11
N2 - Glycogen storage disease type II (GSD II), also known as Pompe disease, is an autosomal recessive inherited disorder caused by a reduced activity of acid alpha glucosidase (GAA). Two different clinical entities have been described: rapidly fatal infantile and late onset forms. Hearing loss has been described in classic infantile Pompe patients but rarely in late onset cases. The main purpose of this study was to investigate the involvement of the auditory system in a cohort of Italian patients with late onset GSD II. We have enrolled 20 patients, 12 males and 8 females. The auditory system assessment included speech and pure tone audiometry, impedance audiometry and auditory brainstem responses (ABR). A combined interpretation of those tests allowed us to define the origin of the hearing impairment (sensorineural, conductive or mixed). Clinically, all patients but one denied subjective hearing disturbances. On the other hand, audiological evaluation revealed that 21/40 patient ears (52.5%) had a hearing impairment: 57% had a sensorineural deficit, 33% showed a conductive hearing loss whereas 10% presented with a mixed pattern. Our study revealed that, in this group of GSDII late onset patients, the auditory system impairment was more frequently present than thought with a prominent cochlear involvement. Our results emphasize the importance of a routinely auditory function evaluation in all forms of Pompe disease.
AB - Glycogen storage disease type II (GSD II), also known as Pompe disease, is an autosomal recessive inherited disorder caused by a reduced activity of acid alpha glucosidase (GAA). Two different clinical entities have been described: rapidly fatal infantile and late onset forms. Hearing loss has been described in classic infantile Pompe patients but rarely in late onset cases. The main purpose of this study was to investigate the involvement of the auditory system in a cohort of Italian patients with late onset GSD II. We have enrolled 20 patients, 12 males and 8 females. The auditory system assessment included speech and pure tone audiometry, impedance audiometry and auditory brainstem responses (ABR). A combined interpretation of those tests allowed us to define the origin of the hearing impairment (sensorineural, conductive or mixed). Clinically, all patients but one denied subjective hearing disturbances. On the other hand, audiological evaluation revealed that 21/40 patient ears (52.5%) had a hearing impairment: 57% had a sensorineural deficit, 33% showed a conductive hearing loss whereas 10% presented with a mixed pattern. Our study revealed that, in this group of GSDII late onset patients, the auditory system impairment was more frequently present than thought with a prominent cochlear involvement. Our results emphasize the importance of a routinely auditory function evaluation in all forms of Pompe disease.
KW - Alfa-glucosidase
KW - GSDII
KW - Hearing loss
KW - Muscle glycogenosis
KW - Pompe disease
UR - http://www.scopus.com/inward/record.url?scp=84867895309&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84867895309&partnerID=8YFLogxK
U2 - 10.1016/j.ymgme.2012.07.024
DO - 10.1016/j.ymgme.2012.07.024
M3 - Article
C2 - 22958975
AN - SCOPUS:84867895309
VL - 107
SP - 480
EP - 484
JO - Molecular Genetics and Metabolism
JF - Molecular Genetics and Metabolism
SN - 1096-7192
IS - 3
ER -